UBS Group’s Innovator US Equity Accelerated 9 Buffer ETF January XBJA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.13K Buy
100
+39
+64% +$1.25K ﹤0.01% 9137
2025
Q4
$1.95K Buy
+61
New +$1.93K ﹤0.01% 9428
2025
Q3
Sell
-1,939
Closed -$58.4K 11009
2025
Q2
$58.4K Buy
1,939
+179
+10% +$5.13K ﹤0.01% 7651
2025
Q1
$49.7K Buy
1,760
+1,398
+386% +$40.4K ﹤0.01% 7601
2024
Q4
$10.4K Buy
+362
New +$10.3K ﹤0.01% 8296
2024
Q2
Sell
-378
Closed -$10.2K 10176
2024
Q1
$10.2K Buy
+378
New +$9.96K ﹤0.01% 7241
2023
Q2
Sell
-1,008
Closed -$23.5K 9737
2023
Q1
$23.5K Buy
+1,008
New +$23K ﹤0.01% 6968
2022
Q4
Sell
-1,424
Closed -$29K 11199
2022
Q3
$29K Buy
+1,424
New +$31.6K ﹤0.01% 6929

Other funds holding XBJA

UBS Group's XBJA Position: Q1 2026 in Review

UBS Group increased its Innovator US Equity Accelerated 9 Buffer ETF January (XBJA) stake by 64% in Q1 2026, buying an estimated $1.25K and bringing the position to 100 shares worth $3.13K. The position accounts for ﹤0.01% of the portfolio, ranked #9137.

UBS Group first reported a position in XBJA in Q3 2022 and has held it in 8 quarters since. The position peaked at $58.4K in Q2 2025. 45 funds tracked by Wall St. Rank hold XBJA as of Q1 2026.

  • UBS Group held 100 shares of Innovator US Equity Accelerated 9 Buffer ETF January worth $3.13K as of Q1 2026.
  • UBS Group bought 39 Innovator US Equity Accelerated 9 Buffer ETF January shares in Q1 2026, an estimated $1.25K.
  • Innovator US Equity Accelerated 9 Buffer ETF January made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #9137 holding.
  • UBS Group first reported a position in Innovator US Equity Accelerated 9 Buffer ETF January in Q3 2022 and has held it in 8 quarters since.
  • UBS Group's Innovator US Equity Accelerated 9 Buffer ETF January position peaked at $58.4K in Q2 2025.
  • 45 funds tracked by Wall St. Rank held Innovator US Equity Accelerated 9 Buffer ETF January as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.